Dr. Li and his team aim to bridge basic studies of kidney organogenesis and translational applications of stem/progenitor cell-based kidney regeneration and disease modeling, with the long-term goal of rebuilding the kidney. They achieve this by combining state-of-the-art stem cell technologies and engineering methodologies. If you’re interested in using state-of-the-art stem cell technologies to bridge basic and translational kidney studies, to develop novel therapeutic strategies to improve the quality of life of patients with kidney diseases, and to collaborate with bioengineers, please email your CV to Dr. Zhongwei Li at zhongwei.li@med.usc.edu. For more information, visit https://lilab.usc.edu.
Show less
Mentioned in this article: Zhongwei Li, PhD